Healthcare M&A » By The Online Investor Staff, updated Fri., Dec. 6, 8:44 PM
Recent mergers and acquisitions in the Healthcare M&A category.
| This Slide: #4 of 100 |
Slide #4. Akorn, Inc. — VersaPharm
Acquirer:
Akorn, Inc. (NASDAQ:AKRX)
Acquiree:
VersaPharm
Details:
Akorn, Inc. (NASDAQ:AKRX) today announced that it has entered into a definitive agreement to acquire VPI Holdings Corp., the parent company of VersaPharm Incorporated, for $440 million in cash.
Akorn is a generic pharmaceutical company that develops, manufactures and markets generic and branded prescription pharmaceuticals, branded as well as private-label over-the-counter consumer health products and animal health pharmaceuticals. Co.'s segments include: Prescription Pharmaceuticals, which primarily consists of generic and branded prescription pharmaceuticals in a variety of dosage forms including sterile ophthalmics, injectables and inhalants and non-sterile oral liquids, topicals, nasal sprays and otics; and Consumer Health, which primarily consists of branded and private-label over-the-counter products and animal health products dispensed by veterinary personnel.
AKRX SEC Filing Email Alerts Service
Open the AKRX Page at The Online Investor »
|
|||||||||||||||||||||
Open the AKRX Page at The Online Investor (in a new window) »
|
|
Avg. Broker Rec.
 
|
Hold (2.40 out of 4) 13rd percentile
(ranked lower than approx. 87% of all stocks covered)
Based on Zacks ABR data; powered by Xignite |
